Break out is coming Potential 20% profit on confirmed break out with low risk and ideal Risk/Reward ratio.
1st target 12.5$
2nd target as per upper yellow line
Key facts today
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.81 USD
−108.68 M USD
0.00 USD
72.71 M
About Mind Medicine (MindMed) Inc.
Sector
Industry
CEO
Robert Barrow
Website
Headquarters
New York
Founded
2010
FIGI
BBG00F13HYQ7
Mind Medicine (MindMed), Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.
A 51% upside trade idea watchlist add before we moon!NASDAQ:MNMD
Inverse H&S
$10.44 BREAKOUT =🎯$12.25🎯$15.60
Called this one out a few months ago and how RFK Jr. would send the Psychedelic's Stock flying...He did just that after his inauguration. It could keep flying now with momentum!
Not financial advice
MNMD LONGBreakout, CHoCH, volume supporting the move, 20.82 target, march Opex expiration. nothing big, I like the setup. why are we running tho??
The confirmation of Robert F. Kennedy Jr. as the head of the U.S. Department of Health and Human Services could have a positive impact on biotech stocks, particu
Keep a close eye on $MNMDMind Medicine (MindMed) Inc. ( NASDAQ:MNMD ): Technical and Fundamental Analysis
As of February 3, 2025, Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) is trading at $7.26, an increase of $0.47 (approximately 6.92%) from the previous close.
Mind Medicine Inc (MNMD) is an equity in the U.S. market. Th
MNMD: The $36.55 Moonshot or Mirage? Boom or Bust Play!MNMD is displaying significant bullish momentum, recently establishing support at $4.50, where a key gap has formed. This level is now acting as a base for a potential continuation move, setting the stage for an explosive breakout.
The stock is currently approaching the $12.22 weekly resistance lev
MindmedBeautiful cup&handle pattern forming .
Targets remains around 18$ .
Before a decent correction .
Sell a little if necessary, but for me this is a long term hold ( mostly ) .
To the 40-50$ region at least .
MNMDMNMD broke out of my falling wedge .
First target would be around 18$ , with jfk
( if he keeps his promise )
Opening new ways for companies with psychedelic treatments to prosper .
Company Fundamentals also seem quite good to me .
Crash back to 10$ in financial crisis Q2-Q3.
And then there is
MNMD: An optimal buy Call option hereMNMD: An optimal buy Call option here
-Long ABCD pattern.
-Inversed HnS pattern forming.
-Fibo golden zone at 0.168./
-Key level support.
-Logic volume together with spread.
.
Wait n see.
$MNMD looking for a good swing trade. On a more zoomed out NASDAQ:MNMD looks like it’s in a falling wedge. A little double bottom could be forming here as well. Will be accumulating $1500 or so in shares for a short term swing. Risk for me is $6.75 with a goal of $8.50 and leave some running.
WSL
MNMD 600% in 2025With Trump and RFK challenging the stronghold of big pharma, the suppression of psychedelic medicines may soon be over. Analysts have set a price target of $26. Market conditions and fresh speculative details render these companies highly volatile and speculative, as many are in trial phases and are
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of MNMD is 5.80 USD — it has increased by 0.37% in the past 24 hours. Watch Mind Medicine (MindMed) Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Mind Medicine (MindMed) Inc. stocks are traded under the ticker MNMD.
MNMD stock has risen by 9.00% compared to the previous week, the month change is a −15.90% fall, over the last year Mind Medicine (MindMed) Inc. has showed a −42.29% decrease.
We've gathered analysts' opinions on Mind Medicine (MindMed) Inc. future price: according to them, MNMD price has a max estimate of 55.00 USD and a min estimate of 16.00 USD. Watch MNMD chart and read a more detailed Mind Medicine (MindMed) Inc. stock forecast: see what analysts think of Mind Medicine (MindMed) Inc. and suggest that you do with its stocks.
MNMD reached its all-time high on Mar 20, 2017 with the price of 154.80 USD, and its all-time low was 0.01 USD and was reached on Dec 26, 2019. View more price dynamics on MNMD chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
MNMD stock is 6.61% volatile and has beta coefficient of 1.45. Track Mind Medicine (MindMed) Inc. stock price on the chart and check out the list of the most volatile stocks — is Mind Medicine (MindMed) Inc. there?
Today Mind Medicine (MindMed) Inc. has the market capitalization of 418.29 M, it has decreased by −1.99% over the last week.
Yes, you can track Mind Medicine (MindMed) Inc. financials in yearly and quarterly reports right on TradingView.
Mind Medicine (MindMed) Inc. is going to release the next earnings report on May 14, 2025. Keep track of upcoming events with our Earnings Calendar.
MNMD earnings for the last quarter are −0.41 USD per share, whereas the estimation was −0.29 USD resulting in a −39.93% surprise. The estimated earnings for the next quarter are −0.36 USD per share. See more details about Mind Medicine (MindMed) Inc. earnings.
Mind Medicine (MindMed) Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
MNMD net income for the last quarter is −34.74 M USD, while the quarter before that showed −13.68 M USD of net income which accounts for −153.88% change. Track more Mind Medicine (MindMed) Inc. financial stats to get the full picture.
No, MNMD doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 15, 2025, the company has 74 employees. See our rating of the largest employees — is Mind Medicine (MindMed) Inc. on this list?
Like other stocks, MNMD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Mind Medicine (MindMed) Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Mind Medicine (MindMed) Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Mind Medicine (MindMed) Inc. stock shows the sell signal. See more of Mind Medicine (MindMed) Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.